Stock Analysis

ADX announced on 2 November 2026 that it had executed an Energy Investment Agreement with Empyrean Energy plc on 30 October 2026. The agreement follows a binding heads of agreement signed on 13 September 2026, under which Empyrean paid a non-refundable option fee of …

AMP released its third quarter 2026 cashflows andBusinessupdate on 15 October 2026. Platforms net cashflows, excluding pension payments, were $1.5 billion, up 20% on the $1.2 billion recorded in the same quarter of 2025. Platforms funds under management reached $93.6 billion. The company said …

FOS released its trading update for the three months to 30 September 2026 on 14 October 2026. The company said unauditedRevenueand EBITDA were above the figures it had guided in its 3 September 2026 update, reflecting improved sales, a larger order book and the …

Argenica released its quarterly update and Appendix 4C on 30 October 2026. The company said it had completed a Phase 2 clinical trial of xaranetide in acute ischaemic stroke patients at Australian hospitals during 2025, and it is now designing a targeted late-stage trial …

BCAL released its quarterly activities report and Appendix 4C on 30 October 2026. The company completed clinical validation of BREASTESTplus 2 for women aged 30 and over across all breast densities. In the validation study the test showed a sensitivity of 80.3% and a …

Alpha HPA announced on 2 November 2026 that it had commenced the progressive drawdown of funds from its $160 million commitment from the Critical Minerals Facility, managed by Export Finance Australia. Funds are to be disbursed monthly to fund Stage 2 HPA First Project …

Buxton released its quarterly activities report on 26 October 2026 for the three months to 30 September 2026. The company said it had secured about 14.2 square kilometres of 100%-owned tenure at Arivaca in Arizona's Laramide porphyry belt, after an application in August 2026.